⌘K
Loading ticker…
Apyx Medical Corporation Common Stock · Healthcare · Medical Equipment
As of 2026-06-26, Apyx Medical Corporation Common Stock (APYX) has a 3-month relative strength percentile of 68 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.7%, relative volume 0.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
68 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
APYX is in a stage 2 uptrend, week 6. Currently in a 12-day base; basing ADR 7.0% (broad 7.6%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 13.4% / 25.1%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
APYX is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $4M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M |
| VXFVanguard Extended Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | APYX Jan avg: 4.07% median: 3.00% win: 50% σ: 18.78% n: 4 2022-04-12 → 2026-05-29 | APYX Feb avg: -3.23% median: -2.78% win: 50% σ: 12.57% n: 4 2022-04-12 → 2026-05-29 | APYX Mar avg: -9.82% median: -8.45% win: 25% σ: 19.84% n: 4 2022-04-12 → 2026-05-29 | APYX Apr avg: -8.57% median: -9.76% win: 40% σ: 20.60% n: 5 2022-04-12 → 2026-05-29 | APYX May avg: 46.51% median: 50.00% win: 100% σ: 29.45% n: 5 2022-04-12 → 2026-05-29 | APYX Jun avg: 0.36% median: -11.12% win: 25% σ: 30.24% n: 4 2022-04-12 → 2026-05-29 (current) | APYX Jul avg: 14.74% median: 6.31% win: 75% σ: 32.96% n: 4 2022-04-12 → 2026-05-29 | APYX Aug avg: -13.52% median: -9.42% win: 25% σ: 19.34% n: 4 2022-04-12 → 2026-05-29 | APYX Sep avg: -13.05% median: -14.20% win: 25% σ: 17.04% n: 4 2022-04-12 → 2026-05-29 | APYX Oct avg: 4.72% median: 2.86% win: 50% σ: 29.50% n: 4 2022-04-12 → 2026-05-29 | APYX Nov avg: 2.05% median: 17.70% win: 75% σ: 47.09% n: 4 2022-04-12 → 2026-05-29 | APYX Dec avg: 7.35% median: 4.58% win: 50% σ: 19.63% n: 4 2022-04-12 → 2026-05-29 |